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Abstract 
Monocarboxylate transporter-1 (MCT-1) is a transmembrane transporter for monocarboxylates 
including lactate and pyruvate. Silencing Mct1 by its small interfering RNA (siRNA) suppressed the 
expression of marker genes for osteoblast differentiation, namely, Tnap, Runx2, and Sp7, induced by 
BMP-2 in mouse myoblastic C2C12 cells. Mct1 siRNA also suppressed alkaline phosphatase activity 
as well as expressions of Tnap and Bglap mRNAs in mouse primary osteoblasts. On the other hand, 
Mct1 siRNA did not have effects on the Smad1/5 or ERK/JNK/AKT pathways in BMP-2-stimulated 
C2C12 cells, while it up-regulated the expression of mRNA for p53 (Trp53) and nuclear 
accumulation of p53 in C2C12 cells in a BMP-2-independent manner. Suppression of osteoblastic 
differentiation by Mct1 siRNA in C2C12 cells was abolished by co-transfection of Trp53 siRNA. All 
of these results suggest that MCT-1 functions as a positive regulator of osteoblast differentiation via 
suppression of p53.  
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Introduction 
Monocarboxylate transporters (MCTs) are a group of transmembrane transporters for 
monocarboxylates. Among 14 subtypes identified thus far, inward and outward transportation of H+ 
and monocarboxylates, such as lactate and pyruvate, have been shown to be mediated by 4 types of 
MCTs, i.e., MCT-1, -2, -3, and -4.1 Of those, MCT-1 is ubiquitously expressed, and its major 
physiological role is believed to facilitate influx and efflux of L-lactate across the plasma membrane 
depending on the cellular metabolic state. For example, L-lactate absorbed through MCT-1 is used 
for gluconeogenesis in parenchymal cells of the liver and the proximal convoluted tubule cells of the 
kidney.2 Furthermore, L-lactate and ketone bodies absorbed through MCT-1 are used as fuel for 
aerobic respiration in cardiac muscle and red skeletal muscle cells.3 On the other hand, most cells 
must release L-lactate to outside of the cell via MCT-1 when glycolysis is predominant under a 
hypoxic condition. Transportation of H+ together with L-lactate through MCT-1 prevents 
intracellular acidification, which is preferable for maintaining an intracellular condition suitable for 
high glycolytic flux.3 
In our previous study, we demonstrated that MCT-1 is required for chondrocyte death 
induced by interleukin-1β (IL-1β), which occurred in a nitric oxide- and reactive oxygen species 
(ROS)-dependent manner.4 Furthermore, MCT-1 knockdown by siRNA strongly suppressed 
expression of phagocyte-type NADPH oxidase (NOX-2), an enzyme specialized for production of 
ROS, in mouse chondrocyte-like ATDC5 cells. We also found that an MCT-1-dependent increase in 
mitochondrial ROS production was required for late phase activation of NF-κB, which led to 
expression of NOX-2 in ATDC5 cells stimulated by IL-1β. Together, those observations suggested 
that MCT-1 might have possible hidden functions, in addition to regulation of energy metabolism 
and intracellular pH. MCT-1 is also known to be ubiquitously expressed in various tissues including 
bones.1, 5 Furthermore, we have shown that acetoacetate enhanced and β-hydroxybutyrate suppressed 
mineralization by mouse osteoblastic MC3T3-E1 cells, in both the presence and absence of bone 
morphogenetic protein (BMP)-2.6 These ketone bodies are known to be transported across plasma 
membranes via MCT-1,1 and knockdown of Mct1 nullified their effects.6  
Those findings led us to explore the role of MCT-1 in osteoblast differentiation in the 
present study, for which we chose osteoblastic differentiation of mouse myoblastic C2C12 cells 
induced by BMP-2 as a model of osteoblast differentiation.7 BMP-2, a cytokine that belongs to the 
transforming growth factor-β superfamily, binds to a complex of type I and type II receptors, and 
induces phosphorylation and activation of Smad-1, -5, and -8, transcription factors that activate the 
expression of Runx2, a master transcription factor for osteoblast differentiation, while BMP 
receptors also activate the MAP-kinase pathway.8 Based on the present results, we herein describe a 
function of MCT-1 in BMP-2-induced osteoblast differentiation, including the Smad and MAP-
 5 
kinase pathways. In addition, we also examined the role of MCT-1 in activation of p53, a negative 
regulator of osteoblast differentiation.9  
 
Results 
Mct1 knockdown suppressed osteoblast differentiation of C2C12 cells after stimulation by 
BMP-2. In C2C12 cells, the expression level of Mct1 mRNA was the highest among mRNAs for 
MCT-1, -2, -3, and -4 (Suppl. Fig. S1a), known transmembrane transporters for monocarboxylate 
such as lactate and pyruvate.1 Hence we silenced Mct1 mRNA expression by introducing Mct1 
siRNA into C2C12 cells (Suppl. Fig. S1b). Intracellular lactate in Mct1 siRNA-introduced C2C12 
cells was 3 times higher than that in cells introduced with the control siRNA (Suppl. Fig. S1c). 
Intracellular lactate was thought to be generated as a result of glycolysis. Thus, a higher 
concentration of intracellular lactate is assumed to be the result of suppressed efflux of lactate 
through MCT-1 in Mct1 siRNA-introduced C2C12 cells.  
 Mct1 knockdown did not have effects on proliferation of C2C12 cells in either the presence 
or absence of BMP-2 (Suppl. Fig. S1d). It is conceivable that differentiation of C2C12 cells into 
osteoblast-like cells induced by BMP-2 mimics the differentiation of osteoblasts.10 Hence, we 
analyzed the effect of Mct1 knockdown on osteoblastic differentiation of C2C12 cells stimulated by 
BMP-2. We found that the increase in number of ALP-positive cells, enhanced ALP activity, and 
increased expression of tissue-nonspecific ALP gene (Tnap) in C2C12 cells after exposure to BMP-2 
were each suppressed by introduction of Mct1 siRNA (Fig. 1a-c). In addition, Mct1 knockdown had 
a tendency to suppress mineralization of extracellular matrices of C2C12 cells cultured in the 
presence of BMP-2 (Suppl. Fig. S2). Furthermore, Mct1 knockdown suppressed BMP-2-induced 
expression of genes for transcription factors required for osteoblast differentiation, i.e., Runx2 
(Runx2) and Osterix (Sp7), in C2C12 cells following stimulation with BMP-2 (Fig. 1c). Also, down-
regulation of ALP activity and Tnap expression were observed in C2C12 cells treated with 
AZD3965, a specific inhibitor for MCT-1 (Fig. 1d, e). These results suggest that lowered expression 
of MCT-1 or its inhibition suppresses BMP-2-induced differentiation of C2C12 cells into osteoblast-
like cells.  
 
Mct1 knockdown suppressed expression of ALP in mouse calvarial osteoblasts. In order to 
investigate the role of MCT-1 in expression of osteoblast phenotypes in differentiated osteoblasts, we 
examined the effects of Mct1 knockdown on ALP activity and expression of osteoblast marker genes 
in mouse primary osteoblasts cultured with or without BMP-2. Mct1 knockdown reduced ALP 
activity in primary cultures of osteoblasts even in the presence of BMP-2 (Fig. 2a, b), while it also 
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suppressed BMP-2-induced expression of mRNAs for Tnap and Bglap. In contrast, Runx2 and Sp7 
mRNA expressions were not affected by Mct1 siRNA (Fig. 2c).  
 
Mct1 knockdown had no effects on Smad and MAPK pathways in C2C12 cells stimulated by 
BMP-2. To elucidate the mechanism by which Mct1 knockdown suppresses osteoblast 
differentiation of C2C12 cells induced by BMP-2, we investigated the effects of Mct1 knockdown on 
the downstream signaling pathways of BMP-2.11 Initially, we examined the effect of Mct1 
knockdown on the Smad pathway. Phosphorylation of Smad1/5 after addition of BMP-2 was not 
affected by introduction of Mct1 siRNA (Fig. 3a and Suppl. Fig. S3a). While it is well known that 
Id1 is a target gene of Smad1/5/8, introduction of Mct1 siRNA did not have an effect on BMP-2-
induced expression of luciferase activity in C2C12 cells transfected with the Id1 promotor-coupled 
luciferase gene (Fig. 3b) or mRNA expression of the intrinsic Id1 induced by BMP-212 (Fig. 4c). 
Furthermore, the expression of Dlx2, another target gene of BMP-2 in C2C12 cells,13 was not 
affected by Mct1 knockdown (Fig. 3d). These results indicated that reduced expression of Mct1 
down-regulated osteoblastic differentiation via mechanisms other than modulation of the Smad 
pathway. Next, we examined the effect of Mct1 knockdown on activation of the MAP kinase 
pathway, which is known to positively regulate osteoblast differentiation.14 Introduction of Mct1 
siRNA did not have effects on phosphorylation of ERK1/2, JNK (Fig. 3e and Suppl. Fig. S3b, c), or 
AKT (Suppl. Fig. S4a, b). We concluded that the MAP kinase pathway is not a major point of action 
of MCT-1 for promotion of BMP-2-induced osteoblast differentiation. 
 
Mct1 knockdown enhanced expression of Trp53 and Klf4. It has been reported that a reduced 
concentration of serum in culture medium induces myogenic differentiation of C2C12 cells in the 
absence of BMP-2.7 However, the role of MCT-1 in myogenic differentiation has not been described, 
thus we analyzed the effect of Mct1 knockdown on differentiation of C2C12 cells into myocyte-like 
cells. It was not significant, but expression of mRNAs for MyoD and Myoginin, myocyte marker 
genes,15, 16 was slightly augmented by introduction of Mct1 siRNA in C2C12 cells (Suppl. Fig. S5). 
It was previously reported that activation of Klf4 by ERK5 promoted myotube formation in cultures 
of C2C12 cells,17 while the present results showed that the expression of Klf4 mRNA in C2C12 cells 
following introduction of Mct1 siRNA was increased in both the absence and presence of BMP-2 
(Fig. 4a). It has also been shown that Klf4 directly binds to Runx2 and inhibits its transcriptional 
activity.18 However, Mct1 knockdown suppressed the expression of Runx2 in C2C12 cells (Fig. 1c), 
indicating that increased Klf4 gene expression is not the sole mechanism for suppression of 
differentiation of C2C12 cells into osteoblast-like cells. On the other hand, we noted increased 
expression of mRNA for Trp53, the gene for p53 (Fig. 4b).  
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In order to clarify the relationship between Trp53 and Klf4 in Mct1 siRNA-introduced 
C2C12 cells, a time course study of the expression of each gene was performed. An increase in 
expression of Trp53 in Mct1 siRNA-introduced C2C12 cells was observed before induction of 
differentiation caused by lowering the serum concentration in both the presence and absence of 
BMP-2 (Fig. 4b). On the other hand, as shown in Figure 4a, increased expression of Klf4 mRNA was 
observed at least 24 hours after induction of both myogenic and osteoblastic differentiation by 
cultivation of C2C12 cells in the absence and presence of BMP-2. It was previously found that p53 
induces the expression of Klf4,19 thus it is plausible that Trp53, whose expression was shown to be 
augmented by Mct1 knockdown, induces Klf4 expression. We confirmed functional increments of 
p53 and Klf4 in Mct1-silenced C2C12 cells by the enhanced expression of p21 (Fig. 4c), one of the 
target genes of both p53 and Klf4.19 Furthermore, fluorescent immunostaining of p53 revealed that 
both p53 protein expression and its accumulation in nuclei were enhanced in Mct1-silenced C2C12 
cells (Fig. 4d).  
 
MCT-1 positively regulated osteoblastic differentiation of C2C12 cells via down-regulation of 
p53. The suppression of BMP-2-induced ALP activity in C2C12 cells by Mct1 siRNA was recovered 
by co-introduction of Trp53 siRNA (Fig. 5a, b). Klf4 siRNA showed a tendency to rescue C2C12 
cells from the reduced ALP activity induced by Mct1 siRNA, though the effect was not significant 
and weaker than that of Trp53 siRNA. In addition, co-introduction of Trp53 siRNA recovered the 
suppressed expression of Sp7 mRNA as well as that of Tnap mRNA (Fig. 5c). Together, these results 
suggested that Mct1 knockdown induces increased expression of p53, leading to suppressed 
osteoblastic differentiation of C2C12 cells in the presence of BMP-2.  
 
Discussion 
Although it has been widely reported that MCT-1 plays important roles in cellular energy 
metabolism,1-3 its other biological roles have rarely been discussed. In the present study, we found 
two novel functions, the requirement of MCT-1 for osteoblast differentiation, and its activity to 
suppress expression and activation of p53. Differentiation of myoblastic C2C12 cells into osteoblast-
like cells following exposure to BMP-2 is regarded as a model of osteoblast differentiation from cells 
in a lower stage of differentiation, such as mesenchymal stem cells.20 Using this model, we found 
that Mct1 knockdown suppressed osteoblastic differentiation of C2C12 cells.  
 We also noted that Mct1 siRNA suppressed the expressions of Tnap and Bglap, as well as 
ALP activity in not only C2C12 cells but also mouse primary osteoblasts (Fig. 2a-c). On the other 
hand, the expressions of Runx2 and Sp7 were not affected by Mct1 siRNA in primary osteoblasts 
(Fig. 2c). Since Mct1 knockdown suppressed the expression of Tnap and Bglap, late-phase marker 
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genes of osteoblasts, without changing that of Runx2 and Sp7 in differentiated osteoblasts, there is a 
possibility that MCT-1 promoted the expression of these late-phase differentiation marker of 
osteoblasts by regulating the other transcription factors or signaling system independently of the 
induction of Runx2 and Sp7.21  
 We also did not find a noticeable effect of Mct1 siRNA on well-known events downstream 
of stimulation by BMP-2, namely, expression of the Id1 gene and phosphorylation of Smad-1/5, 
ERK, JNK, or AKT (Fig. 3, Suppl. Figs. S3 and S4). These results suggested that Mct1 knockdown 
suppresses osteoblast differentiation of C2C12 cells in a BMP-2-independent manner. It is 
interesting that Mct1 siRNA augmented the expression of Trp53, Klf4, and p21 in C2C12 cells in 
both the presence and absence of BMP-2 (Fig. 4a-c), indicating that MCT-1 suppresses expression of 
those genes independent of BMP-2. Increased expression of p21 mRNA in Mct1-silenced C2C12 
cells is consistent with induction of Trp53 expression, since p21 is one of the target genes of p53.22 It 
is well known that p53 suppresses cell proliferation by induction of the expression of p21, a cyclin-
dependent kinase inhibitor. It is reported that galectin-3 stabilizes p21 protein in prostate cancer 
cells.23 There is a possibility that instability of p21 is one of the reasons why the augmented 
expression of mRNAs for p51 and p21 did not have an effect on the proliferation of C2C12 cells 
harboring Mct1 siRNA.  
 The well-known tumor suppressor p53 has a diverse array of biological functions, among 
which DNA repair, regulation of cell cycle and senescence, and induction of apoptosis are regarded 
as the most important roles of this transcription factor.24 In addition, reports have shown the role of 
p53 in differentiation of various types of cells,25 such as osteoblasts, in which p53 suppresses 
transcription of the RUNX2 gene.26 It is also known that glycolysis is very active in tumor cells even 
in aerobic conditions and, as a consequence, tumor tissues are acidified by the enhanced production 
and excretion of lactate.27 Upregulated expression of MCT-1 in p53-null and -mutated tumor cells 
has also been reported.28, 29 On the other hand, regulation of p53 expression by MCT-1 has not been 
previously examined. The present findings showed that Mct1 knockdown enhances the expression of 
Trp53 (Fig. 4), indicating MCT-1 as a negative regulator of p53 expression.  
 Klf4 is also known to be a multifunctional protein and has been shown to be an essential 
factor for induction of pluripotent stem cells.30, 31 In addition, a report noted that Klf2 and Klf4 
function as positive regulators of myotube formation by C2C12 cells.17 In our experimental settings, 
the effect of Mct1 knockdown on expression of Myogenin, a marker gene of myogenic 
differentiation, was small. Co-transfection of Klf4 siRNA did not have a significant effect on the 
expression of Myogenin mRNA in Mct1-silenced C2C12 cells (Suppl. Fig. S5). Therefore, enhanced 
expression of Klf4 in Mct1-silenced C2C12 cells (Fig. 4a) did not have an appreciable role in 
differentiation of C2C12 cells into myocyte-like cells (Suppl. Fig. S5). On the other hand, 
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introduction of Trp53 siRNA significantly enhanced the expression of Myogenin gene in Mct1-
silence C2C12 cells (Suppl. Fig. S5), indicating that p53 has an ability to suppress myogenic 
differentiation in C2C12 cells. And it might be concluded that p53 does not have an activity to make 
direction of differentiation of C2C12 cells.  
In a recent report, it was described that lactate incorporated through MCT-1 stabilized HIF-
1α, which caused promotion of osteoblast differentiation.32 Since it was also reported that HIF-1α 
enhances the expression of Trp53.33 To examine if HIF-1α played an important role in induction of 
Trp53 in our experimental settings, we performed immunostaining of C2C12 cells for HIF-1α with 
or without introduction of Mct1 siRNA. Mct1 siRNA, however, did not have a noticeable effect on 
the expression or nuclear accumulation of HIF-1α protein in C2C12 cells (Suppl. Fig. S6). Hence, it 
seems unlikely that HIF-1α plays an important role in the induced expression of Trp53 after Mct1 
knockdown. 
Another study showed that aerobic glycolysis suppresses p53 activation in cancer cells.34 
In the present experiments, the amount of intracellular lactate was found to be increased in Mct1-
silenced C2C12 cells (Supple. Fig. S1c), indicating a decrease in excretion of lactate via MCT-1 in 
those cells. Since lactate dehydrogenase catalyzes both the reduction of pyruvate into lactate and 
oxidation of lactate into pyruvate, it can be speculated that lactate accumulation in cytosol suppresses 
the former reaction and facilitates the latter, which might reduce the efficacy of glycolysis by 
lowering the NAD+/NADH ratio. We observed reduced amounts of incorporated L-glucose in Mct1 
siRNA-introduced C2C12 cells (Suppl. Fig. S7). In addition, osteoblastic differentiation of C2C12 
cells when cultured in DMEM containing a low level of L-glucose was suppressed (Suppl. Fig. S8). 
Therefore, there is a possibility that suppression of glycolysis promotes p53 activation and 
osteoblastic differentiation in Mct1-silenced cells.  
 In conclusion, we found that MCT-1 facilitates osteoblast differentiation via suppression of 
p53 expression and activation, thus knockdown of the Mct1 gene was shown to increase p53 activity, 
which induced the expression of Klf4 and p21. We speculate that the p53 pathway is involved in 
inhibition of the expression of Runx2 and Sp7, as well as the marker genes of osteoblasts including 
Tnap and Bglap. 
 
Methods 
Ethical approval statement 
All the experimental protocols were approved by Showa University Animal Experiment Facility and 
Showa University Genetic Recombination Laboratory. We confirm that all the experiments were 
performed in accordance with the relevant guidelines and regulations. 
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Reagents 
Recombinant human BMP-2 was obtained from R&D Systems (Minneapolis, MN, USA). AZD3965, 
a specific MCT-1 inhibitor, was purchased from Cayman Chemical (Ann Arbor, MI, USA). 
Antibodies against smad1, phospho-smad1/5, ERK1/2, phospho-ERK1/2, ERK5, phospho-ERK5, 
JNK, phospho-JNK, p38MAPK, phospho-p38MAPK, AKT, and phosphor-AKT were obtained from 
Cell Signaling Technology (Beverly, MA, USA). Antibodies against myosin heavy chain (MF-20), 
p53, and HIF-1α were obtained from Developmental Studies Hybridoma Bank (Iowa City, IA, 
USA), Abcam (Cambridge, UK), and GeneTex, Inc. (Irvine, CA, USA), respectively. 
 
Cell cultures 
C2C12 cells were purchased from RIKEN BioResource Center (C2C12 #RCB0987, Tsukuba, Japan) 
and grown in Dulbecco’s modified Eagle’s medium (DMEM, Wako Pure Chemical Industries, 
Osaka, Japan) supplemented with 15% fetal bovine serum (FBS). To induce differentiation into 
osteoblast-like cells, the medium was replaced with DMEM supplemented with 2.5% FBS and 300 
ng/mL BMP-2, while myotube formation was induced by replacing the medium with DMEM 
supplemented with 2.5% FBS. Mouse primary osteoblasts were isolated from calvaria of neonatal 
ddY mice and grown in αMEM (Wako Pure Chemical Industries) supplemented with 10% FBS. 
Osteoblast phenotypes were induced by stimulation with 10% FBS and 300 ng/ml BMP-2 in the 
same medium. StealthTM siRNAs (Invitrogen, Carlsbad, CA, USA) for mouse Mct1, Trp53, and Klf4, 
and negative control siRNA were introduced into 40-50% confluent cells using LipofecttamineTM 
RNAiMAX (Invitrogen) by reverse transfection. BMP-2 was added to the cultures at 24 hours after 
siRNA introduction. 
 
Real-time RT-PCR 
Total RNA was extracted from cells using TRIzol reagent (Invitrogen) according to the 
manufacturer’s instructions. Reverse transcription reactions were performed using ReverTra ACE 
RT qPCR master Mix (TOYOBO Co. Ltd., Osaka, Japan). Quantitative real-time RT-PCR was 
performed using a TaqManTM Gene Expression Assay (Applied Biosystems, Carlsbad, CA, USA). 
The assay IDs of the genes were as follows: Gapdh, Mm99999915_g1; Mct1, Mm01306379_m1; 
Mct2, Mm00441442_m1; Mct3, Mm00445115_m1; Mct4, Mm00446102_m1; Tnap, 
Mm00475834_m1; Runx2, Mm00501584_m1; Sp7, Mm04209856_m1; Bglap, Mm03413826_mH; 
Dlx2, Mm00438427_m1; Trp53, Mm01731290_g1; p21, Mm00432448_m1; Klf4, 
Mm00516104_m1; and Id1, Mm00775963_g1. Amplification signals from the target genes were 
normalized against that of Gapdh.  
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Cell proliferation assay 
C2C12 cells were plated at a density of 1×104 cells/well in 96-well plates, and cultured in the 
presence or absence of BMP-2 (300 ng/mL) for various periods up to 72 hours. At the end of each 
culture period, cells were incubated for 1 hour with solution from a CellTiter 96® Aqueous One 
Solution cell proliferation assay kit (Promega, Madison, WI, USA), then MTS-formazan was 
determined by reading absorbance at 490 nm.  
 
Determination of intracellular lactate 
C2C12 cells were plated at a density of 5×105 cells/well in 6-well plates and cultured for 24 hours, 
then washed with PBS and homogenized in 1% Nonidet P-40 (200 μL) under sonication on ice. 
Lactate concentrations in the cell lysates were determined using F-kit D-lactic acid/L-lactic acid 
(J.K. International, Tokyo, Japan), according to the manufacturer's instructions.  
 
ALP activity staining 
Cells were plated in 96-well plates at a density of 1×104 cells/well, and cultured for 72 hours in the 
presence or absence of BMP-2 (300 ng/mL). Cells were fixed for 30 minutes in 4% 
paraformaldehyde and washed with PBS, then incubated for 30 minutes at 37°C with 100 mmol/L 
Tris-HCl buffer (pH 8.5) containing 270 μmol/L naphthol AS-MX phosphate (Sigma-Aldrich) and 
1.4 mmol/L Fast blue BB (Sigma-Aldrich). After washing with tap water, they were observed under 
a microscope. 
 
Determination of ALP activity 
Cells were cultured in the same conditions as described in the ALP activity staining subsection 
above, then washed with PBS and homogenized with 1% Nonidet P-40 (50 μL) under sonication on 
ice. Cell lysates (10 μL) were added to 50 μL of 0.2 mol/L Tris–HCl buffer (pH 9.5) containing 1 
mmol/L MgCl2 and 12.5 mmol/L disodium p-nitrophenyl phosphate (Wako Pure Chemical 
Industries). After incubation for 15 minutes at 37°C, reactions were terminated by addition of 50 µL 
of 0.5 mol/L NaOH and absorbance of the reaction mixture at 405 nm was read using a micro-plate 
reader (SH-1000, Corona Electric, Ibaraki, Japan). The increase in absorbance in 15 minutes was 
divided by the amount of cellular protein and the obtained value was used to express the specific 
activity of ALP. 
 
Alizarin red staining 
Cells were plated in 96-well plates at a density of 1×104 cells/well, and cultured for 4 days in the 
medium described above in the presence or absence of BMP-2 (300 ng/mL), followed by additional 
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3-day culture in DMEM supplemented with 2.5% FBS, ascorbic acid (50 µg/mL), β-
glycerophosphate (10 mmol/L), and dexamethasone (10 nmol/L). Cells were washed with PBS, fixed 
in 95% methanol, stained with 1% alizarin red S (pH 6.3 – 6.5) (Wako Pure Chemicals) for 5 min, 
and washed with water to remove unbound dye. Calcified nodules visualized by alizarin red S were 
observed under a microscope. For evaluation of calcium deposition, alizarin red S bound to the cell 
matrices was dissolved in 10% (w/v) cetylpyridinium chloride in water and quantified by measuring 
its absorbance at 570 nm. 
 
Immunostaining of myosin heavy chain protein 
C2C12 cells were plated in 96-well plates at a density of 1×104 cells/well and cultured for 6 days. 
Next, they were fixed for 30 minutes in 4% paraformaldehyde, then washed with PBS, permeated 
with 0.1% Triton X-100 in PBS for 5 minutes, and incubated overnight at 4°C with 0.5 μg/mL of a 
mouse anti-αMHC monoclonal antibody in PBS containing 10% rabbit serum. After washing again 
with PBS, cells were incubated for 30 minutes with Histofine® Simple StainTM MAX PO (MULTI) 
(Nichirei. Co., Tokyo, Japan). Finally, the reaction products were visualized using a Histofine AEC 
substrate kit (Nichirei Co., Tokyo, Japan).  
 
Immunostaining of p53 and HIF-1α 
C2C12 cells were fixed for 20 minutes in 4% paraformaldehyde at room temperature, then 
permeated with 0.1% Triton X-100 in PBS for 5 minutes. Next, they were incubated overnight at 4°C 
with 0.5 μg/mL of anti-p53 antibody or anti-HIF-1α in PBS containing 10% rabbit serum, followed 
by incubation for 45 minutes at room temperature with Alexafluor-488-conjugated secondary 
antibody (Invitrogen) diluted in PBS (1:100). Nuclei were stained with 4’,6’-diamidine-2’-
phenylindole dihydrochloride (DAPI) and fluorescence was observed using a BZ-9000 microscope 
(KEYENCE, Osaka, Japan).  
 
Western blot analysis 
C2C12 cells were lysed in 10 mmol/L Tris-HCl (pH 7.8) with 1% Nonidet P-40, 0.15 mol/L NaCl, and 
a protease inhibitor mixture containing EDTA (Roche Applied Science, Penzberg, Germany). Cell 
lysates (5 μg of protein) were subjected to SDS-PAGE (10% polyacrylamide gel) under a reducing 
condition. Following electrophoresis, proteins were transferred onto PVDF membranes and incubated 
overnight at 4°C with the primary antibodies against smad1, phospho-smad1/5, ERK1/2, phospho-
ERK1/2, ERK5, phospho-ERK5, JNK, phospho-JNK, p38 MAPK, phospho-p38 MAPK, AKT, and 
phosphor-AKT, followed by incubation with horseradish peroxidase-conjugated anti-rabbit IgG (GE 
Healthcare, Little Chalfont, UK). Immunoreactive bands were visualized by an enhanced 
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chemiluminescence reaction with an ECL Prime Western Blot Detection System (GE Healthcare). 
Intensity of the chemiluminescent bands was quantitatively analyzed using Versa Doc 5000 MP (Bio-
Rad Laboratories, Hercules, CA, USA). 
 
Luciferase assay 
C2C12 cells were plated in 24-well plates at a density of 1×104 cells/well and transfected with an 
Id1.0-luc reporter plasmid and TK vector (Promega, Madison, WI, USA). Luminescence was 
detected using a Dual-Luciferase Reporter Assay System (Promega) after 24 hours of incubation in 
the presence or absence of BMP-2 (300 ng/ml). The relative activity of firefly luciferase was 
obtained after normalization against the luminescent reaction of Renilla luciferase encoded by the 
TK vector. A pGL4 [luc2/Neo] vector was used as the negative control. 
 
Statistical analysis 
Values are expressed as the mean ± SD. Student’s t-test was used for comparison between the results 
from 2 groups. Tukey test was used for all the pairwise comparisons of the results from 3 or more 
groups. The p-values less than 0.05 were considered statistically significant. 
 
Data Availability statement 
The datasets generated and analyzed during the current study are available from the corresponding 
author on reasonable request. 
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Figure Legends 
 
Figure 1. Suppression of osteoblastic differentiation of C2C12 cells by introduction of Mct1 
siRNA or inhibition of MCT-1 activity. C2C12 cells introduced with control or Mct1 siRNA were 
cultured for 72 hours (a, b) or 48 hours (c) in the absence (-) or presence (+) of BMP-2 (300 ng/mL). 
(a) Results of ALP activity staining. (b) ALP activity in lysates of C2C12 cells. (c) Expressions of 
mRNAs for Tnap, Runx2, and Sp7 were determined using real-time RT-PCR, then normalized 
against that of Gapdh, with the results shown as relative values. (d) C2C12 cells were cultured for 48 
hours in the presence or absence of 1 µmol/L of AZD3965, a specific inhibitor of MCT-1, and with 
(+) or without (-) BMP-2 (300 ng/mL). ALP activity was detected by staining. (e) ALP activity in 
lysates of C2C12 cells cultured under the same conditions. (b, c, e) Values are expressed as the mean 
± SD (n=3-5). **Significantly different from the control group (p <0.01). 
 
Figure 2. Suppressed expression of osteoblast differentiation markers in primary mouse 
osteoblasts by introduction of Mct1 siRNA. Control or Mct1 siRNA was introduced into primary 
osteoblasts isolated from mouse calvaria. The osteoblasts were cultured for 72 (a, b) or 48 (c) hours 
in the absence (-) or presence (+) of BMP-2 (300 ng/mL). (a) ALP activity, detected by staining. (b) 
ALP activity in cell lysates. (c) Expression of mRNAs for Tnap, Bglap, Runx2, and Sp7 was 
analyzed by real-time RT-PCR, then normalized against that of Gapdh, with the results indicated as 
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relative values. (b, c) Data are expressed as the mean ± SD (n=3-5). *, **Significantly different from 
control group (*p <0.05, **p <0.01).  
 
Figure 3. Effects of Mct1 knockdown on Smad and MAP kinase pathways in C2C12 cells after 
stimulation by BMP-2. (a) Control and Mct1 siRNA-introduced C2C12 cells were exposed to BMP-
2 (300 ng/mL) for the indicated periods. Phosphorylation of Smad1/5 and expression of Smad1 at 
various times after addition of BMP-2 were evaluated by western blotting. (b) C2C12 cells harboring 
control or Mct1 siRNA were transfected with an Id1.0-luciferase reporter plasmid and TK vector. 
After incubation for 24 hours with (+) or without (-) BMP-2 (300 ng/mL), light emission intensity 
was measured. The relative firefly luciferase reaction was normalized against the luminescent 
reaction of Renilla luciferase from the TK vector. (c, d) C2C12 cells harboring control or Mct1 
siRNA were incubated for 24 hours with (+) or without (-) BMP-2 (300 ng/mL). The expression of 
Id1 mRNA (c) and Dlx2 mRNA (d) were quantitatively assessed by real-time RT-PCR, then 
normalized against that of Gapdh, with the results shown as relative values. (b, c) Data are expressed 
as the mean ± SD (n=3-5). n.s., not significant. (e) Control and Mct1 siRNA-introduced C2C12 cells 
were exposed to BMP-2 (300 ng/mL) for the indicated periods, then the expressions of ERK1/2 and 
JNK, as well as their phosphorylation were evaluated by western blotting. (a, e) Representative data 
from 3 independent experiments are shown. Quantitative evaluations of phosphorylation of Smad1/5, 
ERK1/2, and JNK are shown in Supplementary Figure S3. Each full-length blots are presented in 
Supplementary Figure S9. 
 
Figure 4. Induction of expression and activation of p53 in C2C12 cells by Mct1 knockdown. (a-
c) Control and Mct1 siRNA-introduced C2C12 cells were cultured for the indicated periods in the 
absence (-) or presence (+) of BMP-2 (300 ng/mL). Expressions of mRNAs for Klf4 (a), Trp53 (b), 
and p21(c) were analyzed by real-time RT-PCR, then normalized against that of Gapdh, with the 
results indicated as relative values. (a-c) Values are expressed as the mean ± SD (n=3-5). *, (d) 
C2C12 cells were introduced with control or Mct1 siRNA, then p53 protein was detected using an 
immunocytochemical method. Nuclei were stained with DAPI. (e) Ratios of p53-positive nuclei in 
cultures of C2C12 cells introduced with control or Mct1 siRNA. (a-c, e) Data are expressed as the 
mean ± SD (n=3-5). **Significantly different from control group (*p <0.05, **p <0.01). 
 
Figure 5. Osteoblastic differentiation suppressed by Mct1 siRNA recovered by introduction of 
Trp53 siRNA. C2C12 cells were introduced with control or Mct1 siRNA in combination with Trp53 
siRNA or Klf4 siRNA, then cultured for 72 (a) or 48 (b) hours in the absence (-) or presence (+) of 
BMP-2 (300 ng/mL). (a) ALP activity in the cultures was detected by staining. (b) ALP activity in 
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lysates of C2C12 cells. (c) Expression of mRNAs for Tnap and Sp7 was analyzed by real-time RT-
PCR, then normalized against that of Gapdh, with the results indicated as relative values. (b, c) Data 
are expressed as the mean ± SD (n=3-5). *Significantly different from control group (*p <0.05). 
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